Takeaways from the 2024 JPM Healthcare Conference
The rain was falling in San Francisco last week. But somehow inside the JPM Morgan Healthcare conference, it was sunny, or at least a lot sunnier than the gloom and doom of 2023 when biotech was in a freefall.
So is the industry in for a rosy 2024 or will it be back to negativity again soon?
TOPICS
(01:35) Optimistic views on the Healthcare industry
(02:04) Discussion on the pros and cons of interest rates on Biotech
(03:49) Analysis of the probable long and short-term effects of weight-loss drugs
(05:01) Application and lack of application in AI in Obesity and Heart diseases
(07:10) The role of Nvidia in drug production and AI
(09:34) Eroom’s law and the effects on Drug production.
(10:09) Artificial Intelligence’s effects on Drug development
(15:36) Initial Public Offering as a mark of lifting market optimism.
(16:11) The optimism and pessimism of IPO in Biotech
(19:22) Addressing Neurological and Psychiatric Diseases in Technology
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
GET IN TOUCH
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter
Shop official CareTalk merch
FOLLOW CARETALK
Spotify
Apple Podcasts
Google Podcasts
Follow us on LinkedIn
#healthcare #healthcarepolicy #healthcarebusiness #healthcaretechnology #healthinsurance #jpmorgan #biotech #healthtech #Ipo
CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing
